Amixin, 125 mg 6 pcs

Pharmgroup:

antiviral immunostimulatory agent – inducer of interferon formation.

Pharmacological action:

Amixin is a low molecular weight synthetic interferon inducer that stimulates formation of interferon alpha, beta and gamma in the body. The main producers of interferon in response to tiloron administration are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration the maximum production of interferon is determined in the sequence intestine – liver – blood in 4-24 hours.

Amixin® has immunomodulatory and antiviral effect.

In human leukocytes it induces synthesis of interferon. It stimulates bone marrow stem cells, and depending on the dose increases antibody formation, decreases the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers.

It is effective against various viral infections including flu viruses, other acute respiratory viral infections, hepatitis viruses and herpesviruses. The mechanism of antiviral action is associated with inhibition of translation of virus-specific proteins in infected cells, resulting in suppression of virus reproduction.

Pharmacokinetics:

After oral administration it is quickly absorbed from the gastrointestinal tract. Bioavailability is 60%. About 80% of the drug is bound to plasma proteins. The drug is excreted practically unchanged in intestine (70%) and kidney (9%). The elimination half-life (T1/2) is 48 hours. The drug is not biotransformed and does not accumulate in the body.

Indications

In adults, treatment and prevention of influenza, other acute respiratory viral infections, treatment of viral hepatitis, A, B and C;
treatment of herpetic and cytomegalovirus infections;

as part of complex therapy of infectious-allergic and viral encephalomyelitis (multiple sclerosis, leukoencephalitis, uveoencephalitis, etc.),

as part of complex therapy of urogenital and respiratory chlamydia, in complex therapy of pulmonary tuberculosis;

In children over 7 years of age – for the treatment of influenza and other acute respiratory viral infections.

Pharmacological effect

Pharmaceutical group:

antiviral immunostimulating agent – inducer of interferon formation.

Pharmaceutical action:

Amiksin is a low-molecular synthetic interferon inducer that stimulates the formation of alpha, beta and gamma interferons in the body. The main producers of interferon in response to the administration of tilorone are intestinal epithelial cells, hepatocytes, T-lymphocytes, neutrophils and granulocytes. After oral administration, the maximum production of interferon is determined in the sequence intestine – liver – blood after 4-24 hours.

Amiksin® has an immunomodulatory and antiviral effect.

Induces the synthesis of interferon in human leukocytes. Stimulates bone marrow stem cells, depending on the dose, enhances antibody formation, reduces the degree of immunosuppression, restores the ratio of T-suppressors and T-helpers.

Effective against various viral infections, including influenza viruses, other acute respiratory viral infections, hepatitis viruses and herpes viruses. The mechanism of antiviral action is associated with inhibition of the translation of virus-specific proteins in infected cells, as a result of which viral reproduction is suppressed.

Pharmacokinetics:

After oral administration, it is quickly absorbed from the gastrointestinal tract. Bioavailability – 60%. About 80% of the drug binds to plasma proteins. The drug is excreted almost unchanged through the intestines (70%) and through the kidneys (9%). The half-life (T1/2) is 48 hours. The drug does not undergo biotransformation and does not accumulate in the body.

Active ingredient

Tiloron

Composition

1 tablet contains Tiloron 125 mg,

excipients:

magnesium carbonate basic,

polyvinylpyrrolidone,

calcium stearate, aerosil,

Vaseline oil,

sugar,

talc,

tropeolin Oh,

titanium dioxide,

gelatin,

beeswax.

Contraindications

Children’s age up to 7 years.
Pregnancy.
Lactation period (breastfeeding).
Hypersensitivity to the drug.

Side Effects

From the digestive system: Symptoms of dyspepsia are possible.

Other: Short-term chills are possible. Allergic reactions.

Interaction

Amiksin is compatible with antibiotics and traditional treatments for viral and bacterial infections.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 30 °C

Shelf life

3 years

Manufacturer

Pharmstandard-Leksredstva, Russia